Key Highlights
- GE HealthCare and Medis Medical Imaging collaborate to integrate Medis QFR in GE’s interventional cardiology suite.
- Medis QFR offers a non-invasive, image-based diagnostic tool for assessing coronary artery physiology.
- Recent studies affirm that QFR-guided strategies improve clinical outcomes in CAD treatments.
Source: Business Wire
Notable Quotes
- “In the assessment of coronary artery disease, QFR represents a significant advancement in how efficiently it can provide critical insights,” – Arnaud Marie, General Manager for Global Intervention at GE HealthCare
- “We are absolutely delighted to be taking this next step with GE HealthCare, a fellow leader in the interventional cardiology domain,” – Maya Barley, CEO at Medis Medical Imaging
SoHC's Take
The collaboration between GE HealthCare and Medis Medical Imaging is a strategic move that not only enhances the technological landscape of interventional cardiology but also promises significant advancements in patient outcomes. By integrating Medis’ non-invasive QFR technology into GE’s established interventional platforms, the partnership is poised to transform how clinicians approach and treat coronary artery disease. This initiative reflects a broader trend in healthcare towards leveraging cutting-edge technology to enable more precise and patient-centric care, emphasizing the growing importance of non-invasive diagnostic methods in clinical settings.
